OTC Distribution in Europe: 2007 Edition Exploring New Frontiers

Table of Contents

• Forward to the 2007 Study of the Distribution of OTC Medicines in Europe by James Dudley
• Distribution of OTC Medicines in Europe - Introduction, Market Definitions and Summary of Key Issues
• 1. The European OTC Self-Medication Market
• 2. Estimates of the Market Size for OTC Medicines of the 18 European Markets for the 2007 OTC Distribution Study
  • 2.1 Brand Models in Europe’s Self-medication Market
• 3. Share of Sales by Market 2006 - Total Pharmaceuticals, OTC Medicines and Semi-Ethical products in Europe
• 4. Efficiency of the European Market Place for OTC Self-medication Medicines
• 5. Major Categories of OTC Self-medication Medicines in Europe’s Main Markets
• 6. Non-prescription Pharmaceuticals and OTC Self-medication Medicines Country Market Growth - Europe 2003 - 2006
• 7. Regulatory Controls on Distributing and Merchandising of OTC Medicines in Europe
• 8. OTC Self-medication Medicines in Europe - Changing Distribution Channel Environments
• 9. Pharmacies in Europe
• 10. Growth of Retail Pharmacies in Europe
• 11. Regulatory Restraints on the Growth of Pharmacy Numbers in Europe
  • 11.1 Restrictions on Pharmacy Numbers in Europe
• 12. The Role of the Retail Pharmacies in Europe
• 13. Economic Pressures on Pharmacies in Europe
  • 13.1. Pressures from the Social Healthcare System
• 14. Self-medication - The Importance of OTC Medicines to Pharmacies in Europe
• 15. Promoting Self-medication in Europe - Restrictions on Merchandising of OTC Medicines in Pharmacies in Different European States
• 16. Retail Price Maintenance of OTC Self-medication Medicines in Europe
• 17. Trends in the Ownership of Pharmacies in Europe
• 18. Small Retail Pharmacy Multiples in Europe
• 19. The Growth of Large Retail Pharmacy Chains in Europe
• 20. Growth of organised of Voluntary Groupings (Virtual chains) of Independent Pharmacies in Europe
  • 20.1 The Difference between Voluntary Trading Organisations and Franchises - European ‘Virtual’ Pharmacy Chains
• 21. Buyer Power and Branding of Pharmacy Retail Groups in Europe
• 22. Supermarket Chains - a growing Force in Pharmacy Retailing in Europe
• 23. The potential Impact of Retail Pharmacy Multiple Groupings on the OTC Selfmedication Consumer Healthcare Companies in Europe
• 24. Threats and Challenges from Internet Pharmacies in Europe
• 28. Consumer Sources of Information about their Health
• 29. Summary Conclusions and Outline Future Agenda for OTC Self-medication in Europe
  • 29.1 Maturing European Non-prescription and OTC Self-medication Market
  • 29.2 Growth Clusters by Country European Non-prescription and OTC Selfmedication Market
  • 29.3 Key Pharmaceutical Wholesalers Retail Groupings in Europe
  • 29.4 Growth of General Sale (GSL) OTC Self-medication Medicines across Europe
  • 29.5 Ambitions of Mass Market Retail Chains to acquire Pharmacies in Europe

Graphs and Figures

• Graph 1: Development of Sales of the Total Non-prescription Bound and OTC Self-medication for 18 major Markets - € millions at Consumer Purchase Prices 2003 - 2007 (estimates)
• Graph 2: Year on Year Sales Gains and Losses OTC Self-medication Sales compared to Semiethical Prescriptions - Europe 2004 - 2007
• Graph 3: Composition of the Self-Medication Market based on % of Sales Derived from Prescription Business - Main European Markets
• Graph 4: Growth of the European Self-Medication Market by Therapeutic Category 2003 - 2006
• Graph 5: Key Markets - Europe 2006 Share of OTC Self-Medication Turnover through Nonpharmacy Channels (excluding prescriptions)
• Graph 6: 18 Key Markets - 2006 % Share of Number of European Pharmacies by Ownership Classification

Tables

• Table 1 Number of Brands by Model Cluster compared to the Number Achieving 70% of Sales in each Cluster
• Table 2Non-prescription Medicines % € Share Europe by Country Total Retail Pharmaceutical, Non-prescription and OTC Self-medication 2006
• Table 3Country % € Share of Non-prescription Medicines’ Country Markets taken by Prescription Sales 2003 compared to 2006 - Main European Markets
• Table 4Europe’s Main Non-prescription and OTC Medicines Markets Total Non-prescription and OTC Self-medication Business % € Growth 2003 - 2006
• Table 5Number of Pharmacies by Country and Population served per Pharmacy 2006
• Table 6 Retail Pharmacy Growth by European State 1986 - 2006
• Table 7Methods of Controlling Pharmacy Numbers in Europe
• Table 8Self-Medication in Europe - Average Pharmacy Margins 1998 - 2006
• Table 9 Pharmacies - Average Annual Consumer Purchases of Non-prescription and OTC Selfmedication Products by European State 2006 Consumer - at Purchase Prices (€000s)
• Table 10 Retail Pharmacies - % Sources of Business Turnover
• Table 11 Constraints on Merchandising in Pharmacies of OTC Self-medication Medicines by European State
• Table 12 Pharmacist’s Attitudes to in-store Visibility and Self-selection for OTC Self-medication Medicines in 12 European States
• Table 13 Self-medication - Status of Retail Price Maintenance on OTC Medicines in European States
• Table 14 Retail Pharmacies in Private and Public Chains in Europe - 2006
• Table 15 Ownership Regulations for Pharmacies in Europe as at 2007
• Table 16 Europe’s Leading Retail Pharmacy Chains 2006/2007
• Table 17 % of Pharmacies in Virtual Retail Pharmacy Chains - 18 European Markets 2006/2007
• Table 18 Emerging Virtual Pharmacy Groupings in Europe 2007
• Table 19 Sources of Information Consumers believe to be Important 5 European Countries - 2004

Chapter 2 Pharmaceutical Wholesalers Vertical Integration Strategies and International Expansion across Europe

• 1. Market and Competitor Influences increasing the Pace of Change along the European Pharmaceutical Supply Chain
• 2. The Role of Wholesalers along the Pharmaceutical Supply Chain in Europe
  • 2.1 Services offered by European Pharmaceutical Wholesalers
    • The basic offer
    • Marketing and training support
    • Additional support services
    • Financial services
• 3. Influence of the Social Healthcare Environment on the Pace of Change in the European Pharmaceutical Supply Chain
• 4. Examination of the Business Strategies of Europe’s Leading Pharmaceutical Wholesalers
• 5. Unfolding Company Strategies across the European Pharmaceutical Wholesaling Industry
• 6. Mergers, Acquisitions and Strategic Alliances within the Pharmaceutical Wholesaling Industry in Europe
• 6.1 Reasons for Mergers and Acquisitions in the European Pharmaceutical Wholesale Industry
• 7. Integrated Channel Managers Driving Change for Europe’s Pharmaceutical Wholesaling Industry
• 8. Vertical Integration and Competitor Strategies of Major European Pharmaceutical Wholesalers
  • 8.1 Manufacturing interests of European Pharmaceutical Wholesalers
  • 8.2 Pan European Pre-Wholesaling - a Growth Industry in the European Pharmaceutical Market
• 9. Pharmaceutical Wholesalers Forward Integration into Retailing in Europe - Alliance Boots, Celesio, Phoenix, OPG, and Galenica
• 10. European Pharmacy Chains directly owned by Pharmaceutical Wholesaler Groups - Alliance Boots, Celesio, Phoenix and OPG (Orfe)
• 11. ‘Virtual’ Pharmacy Chains in Europe
• 12. Pharmacist Owned Wholesale Co-operatives in Europe
• 13. Conclusions - Trends Driving Change among Europe’s Largest Pharmaceutical Wholesaler Groups

Graphs and Figures

• Figure 1: Pharmaceutical Supply Chain in Europe
• Figure 2: Summary of Services Provided by Pharmaceutical Wholesalers
• Graph 1: Pharmaceutical Wholesalers’ Turnover in Europe in 2006 (est)
• Graph 2: Split of European Pharmaceutical Wholesalers’ Turnover between Wholesaling/Logistics and Retail Pharmacy Sales 2006 (est)
• Graph 3: Estimated % Market Share European Pharmaceutical Wholesalers’ based on Wholesaling/Logistics Turnover 2006
• Figure 3: Evolving Pharmaceutical Wholesaler Strategies in Europe

Tables

• Table 1 Europe’s Major Pharmaceutical Wholesalers National and Consolidated % Market Share 2006
• Table 2 Leading Regional Pharmaceutical Wholesalers Rank Position by Country Market 2006
• Table 3 Regional Wholesaler Activities along the Supply Chain 2006
• Table 4 European Pharmaceutical Wholesalers - Examples of Pre-wholesaling Activities 2006
• Table 5 Leading Pharmaceutical Wholesaler Retail Interests in Europe

Chapter 3 Profiles of Companies Driving the European Pharmaceutical Supply Chain

• 1. Summary of Celesio’s Business
  • 1.1 Celesio - Sources of Business Growth 2003 - 2005
  • 1.2 Celsio’s Pharmaceutical Wholesaling Market Share by Country
• Source: Girp/Phoenix/Celsio 2006
  • 1.3 Celesio Pharmacy Retailing
    • UK - Lloydspharmacy Business
    • Italy
    • Czech Republic
    • Norway
    • Netherlands
    • Belgium
    • Ireland
    • Germany
  • 1.4. Celesio - ‘Solutions Division’ - New Business Developments
  • 1.5. Celesio - The Future
• Alliance Boots (Alliance UniChem)
• 2. Summary of Alliance Boots Business
  • 2.1 Alliance Boots Group
• Source: Alliance Boots 2006
  • 2.2. Alliance UniChem emerging Multinational Pharmaceutical Wholesaler
  • 2.3. Alliance Boots Development of an International Brand of Generic Products
  • 2.4. Alliance Boots Pharmaceutical Retailing
  • 2.4. Alliance Boots the Future
• Phoenix
• 3. Summary of Phoenix Business
  • 3.1 Phoenix - Importance of Tamro in the Nordic and Baltic States region
  • 3.2 Phoenix Pre-wholesaling in Europe
  • 3.3 Phoenix in Pharmacy Retailing in Europe
  • MVDA/Linda
  • Numark
  • Escura Apotheek in the Netherlands, Midas in Germany, SPEM in Italy and VMI in Denmark
  • Apteeks 1, Seimos Vaistine and Tamro Aptieku
• 3.2 Conclusions Phoenix
• Sanacorp - CERP Rouen
• 4. Summary of Sanacorp - CERP Rouen Merger
  • 4.2 Conclusions CERP Rouen and Sanacorp Merger
• OPG Netherlands
• 5. Summary of OPG Business
  • 5.1 OPG Sources of Business
  • 5.2 OPG Strategies 2001 to 2006
  • 5.3 Conclusions OPG Netherlands
• A.S. Watson Group
• 6. A.S. Watson Group Expansion into Europe
  • 6.1 A.S Watson in the Netherlands
  • 6.2 A.S Watson in Germany, Poland, Hungary and the Czech Republic
  • 6.3 A.S Watson in the Baltic Region
  • 6.4 A.S Watson in the UK
  • 6.5 A.S Watson in the Ukraine
  • 6.6 A.S Watson in Russia
  • 6.7 A.S Watson Global Buying Policy

• Graph 1: Estimated European Pharmaceutical Wholesale Market Share Resulting from the Merger of CERP Rouen France and Sanacorp Germany

Tables

• Table 1 Celesio Consolidated Sales & Profits (€000) 2003 - 2005
• Table 2 Celesio Source of Growth 2003 - 2005
• Table 3 Celesio Group Turnover by Market and Main Activity - (€ Millions) 2005
• Table 4 Celsio’s Market Share by European Pharmaceutical Wholesale Market
• Table 5 Celesio European Retail Pharmacy Estate 2007 Compared to 2003
• Table 6 Alliance Boots Pharmaceutical wholly owned Wholesaler and Retailer Businesses 2006
• Table 7 Alliance Boots Main Associate Companies 2006
• Table 8 Alliance Boots Pharmaceutical Wholesale Market Share by European Country 2006
• Table 9 Alliance Boots European Retail Pharmacy Estate (pre and post merger) 2004 compared to 2006
• Table 10 Phoenix Pharmaceutical Wholesaling Market Shares - Europe, % € Share 2006
• Table 11 Phoenix Associated Groupings of Independent Pharmacies 2006

Chapter 4 New Channels for Consumer Access to Healthcare in Europe

• 1. Development of Internet Pharmacies in Europe - 2007 Report
  • 1.1 The Internet as a new Challenge in Pharmacy Retailing in Europe
  • 1.2 Internet Applications to the Delivery of Primary Care Services in Europe
• 2. Business to Business Internet Applications in Pharmaceutical Distribution in Europe
  • 2.1 Alliance Boots Internet Portal - pharmology.com in Europe
  • 2.2 Celesio - Internet based Solutions for Pharmacies in Europe
• The GEHE POINT concept has been tailored to local market needs and rolled out to France (OCP POINT), The UK (AAH POINT) and Austria (Herba POINT)
• 3. Business to Consumer (B2C) Internet Pharmacy Retailing Applications in Europe
  • 3.1 Internet Pharmacy Retailing Models in Europe Compared
  • 3.2 ‘Pureplay’ Online Pharmacies in Europe
  • 3.3 DocMorris Building a New Retail Pharmacy Brand in Europe
  • 3.4 The Emergence of Healthcare Portals linked to ‘Clicks and Bricks’ Pharmacies in Europe 9
  • 3.5 OTC Self-Medication - Online Shopping Services from Major Retail Chains in Europe 10
• 4. Opportunities for Business to Consumer e-Commerce for Pharmaceutical Companies in Europe
• 5. Development of Internet Pharmacies in Europe
  • 5.1 Internet Pharmacies in France
  • 5.2 Internet Pharmacies in Germany
  • 5.3 Internet Pharmacies in Italy
  • 5.4 Internet Pharmacies the Netherlands
  • 5.5 Internet Pharmacies in Switzerland
  • 5.6 Consumers Access to Internet Pharmacies in the UK
  • 5.7 Internet Pharmacies in Sweden
  • 5.8 Internet Pharmacies in Denmark
  • 5.9 Internet Pharmacies in Finland and Norway
  • 5.10 Internet Pharmacies in Austria
  • 5.11 Internet Pharmacies in Belgium
  • 5.12 Internet Pharmacies in Spain
  • 5.13 Internet Pharmacies in Czech Republic, Hungary, Slovakia and Slovenia
• 6. Pharmacists’ Attitudes to Consumers Purchasing Online Medicines in Europe
• 7. Legitimacy of Internet Pharmacies for Medicines in Europe
• 8. The Future for Internet Marketing of OTC Medicines in Europe

Tables

• Table 1 Patients and Medical Professionals - Trust in Sponsored Healthcare Web sites Europe
• Table 2 Online Commerce in Pharmaceuticals - Regulatory Status in Europe States Permitting Online Commerce - Revised 2007

Chapter 5 OTC Distribution in Belgium

• 1. The Self-Medication Market in Belgium 2006
• 2. Share of the Belgian Self-medication Market by Category 2006
• 3. Changing Structure of the Belgian Self-medication Market
• 4. Professional or Semi-ethical Pharmaceutical Brands
• 5. Consumer OTC Self-medication Brands in Belgium
• 6. Classification of Medicines in Belgium
• 7. Reimbursement of Non-prescription Medicines in Belgium
• 8. Statutory Control of Prices on OTC Medicines in Belgium
• 9. The Changing Business Environment for Non-prescription medicines in Belgium
• 10. Regulatory Environment for Pharmaceutical Distribution in Belgium
• 11. Mergers and Acquisitions Reshaping Competition between OTC Medicine Companies in Belgium
• 12. Structure of Distribution Channels for Self-Medication in Belgium
• 13. Trends in the Retail Pharmacy Sector in Belgium
• 14. Retail Pharmacy Groupings in Belgium
• 15. Pharmacy Co-operatives in Belgium
• 16. Pharmacy Co-operatives’ Strategies in Belgium
• 17. Celesio Pharmacy Retailing in Belgium
• 18. Independent Pharmacies in Belgium
• 19. Pharmacy Economics in Belgium
• 20. Trade Margins and VAT Manufacturer to Retail Pharmacy Price for Prescription and OTC Medicines in Belgium
• 21. Restructuring of Pharmaceutical Wholesalers in Belgium
• 22. The Future for OTC Medicine Distribution in Belgium

Graphs and Figures

• Graph 1: Belgium Total Self-medication Market compared to the Pharmaceutical Market 2003 - 2006
• Figure 1: Outline Structure of OTC Pharmaceutical Distribution in Belgium
• Graph 2: Pharmacy Development Belgium 1995 - 2005
• Graph 3: Types of Pharmacy - Belgium 2006

Tables

• Table 1 Belgium - Self-Medication Market Category Share and Growth 2003 - 2006(est.)
• Table 2 Leading OTC Self-medication Brands in Belgium
• Table 3 Leading Competitors € Market Share 2006 est % Market Share Non-prescription Sector
• Table 4 Leading Cooperative Retail Pharmacy Groups - Belgium by Number of Pharmacies 2006
• Table 5 Belgian Pharmaceutical Wholesalers’ Market Shares 2006

Chapter 6 OTC Distribution in France

• 1. Introduction - The French OTC Medicines and Non-prescription Pharmaceuticals Market
• 2. Category Sales - OTC Self-medication Market in France
• 3. Self-medication in France - Category Growth
• 4. Structure of the French Non-prescription and OTC Medicines Market
• 5. Non-prescription Pharmaceuticals - Leading Competitors in France
• 6. Medicine Classifications in the French Prescription Pharmaceutical and OTC Medicines Markets
  • 6.1 Classification of Medicines in France
  • 6.2 Legal Definition of Non-prescription Medicines in France
• 7. Pharmacy Monopoly - Ownership Regulations in France Challenged by European Commission
• 8. Advertising Regulations for Non-prescription and OTC Medicines in France
• 9. Use of Trademarks for Medicinal Products in France
• 10. OTC Medicines Linkages to the Prescription Pharmaceuticals Sector in France
  • 10.1 French Pharmaceutical Distribution - Price Control and Reimbursement Systems
  • 10.2 Price Control - Prescription Medicines in France
  • 10.3 Reimbursement Bands for Non-prescription Medicines in France
  • 10.4 Scrutiny of the List of Pharmaceutical Products for Reimbursement in France
  • 10.5 Generic Substitution Targets for Prescription Medicines imposed on French Pharmacies
• 11. Structure of Distribution for Self-Medication in France
  • 11.1 Types of Non-prescription or OTC Medicine Brand in France
• 12. The Retail Pharmacy Channel in France
  • 12.1 Pharmacy Density by Region in France
  • 12.2 Pharmacy - Virtual Chains and Buying Groups in France
  • 12.3 Sources of Business and Economics of French Pharmacies
• 13. Consumer Attitudes towards Pharmacists in France
• 14. Potential for Internet Pharmacies in France
• 15. Prices and Margins of Non-prescription and OTC Medicines in France
• 16. Non-Pharmacy Distribution in France of Consumer Healthcare Products in France
• 17. Pharmaceutical Wholesalers in France
  • Celesio France
  • Alliance Boots France
  • CERP (Coopérative d' Exploitation et de Répartition)
  • Phoenix
• 18. France - The Future for OTC Medicines

Graphs and Figures

• Graph 1: Development of the Total Non-Prescription Bound Market, 2003 - 2006 (est)
• Graph 2: % Share of the OTC Self-medication Market by Category 2006
• Figure 1: Outline Structure of OTC Pharmaceutical Distribution in France

Tables

• Table 1 % Growth of French OTC Self-Medication Sales (excluding prescription business) by Category 2003 - 2006
• Table 2 Leading Competitors’ € Market Share France - Total Non-prescription Bound Market Compared to the OTC Medicines Sector
• Table 3 France - Pharmacy Demographics According to Population
• Table 4 Distribution of Retail Pharmacies by Region in France
• Table 5 Voluntary Trading Groups - Leading Virtual Chains of French Pharmacies
• Table 6 Healthcare - Sources of Information French Consumers believe to be Important
• Table 7 Self-medication - % of French Consumers Treating Common Ailments with an OTC Medicine
• Table 8 France - Pharmaceutical Wholesalers’ Share of Market and Distribution 2005/2006

Chapter 7 OTC Distribution in Germany

• 1. Introduction - The German Non-prescription and OTC Self-medication Medicines Market
  • 1.1 Importance of Prescription Sales for Non-prescription-bound Medicines in Germany
  • 1.2 Wooing Consumers back to Self-medication in Germany - Post 2004 Statutory Health Insurance (GMG) Reforms
• 2. Share of Consumer Purchases of Non-prescription OTC Self-medication Medicines by Therapeutic Category in Germany
  • 2.1 German OTC Self-medication - Growth Rates by Therapeutic Category 2003 - 2006
• 3. Non-prescription and OTC Medicines Leading Competitors - Germany
• 4. The Structure of the German Non-prescription Bound Medicines and OTC Selfmedication Market
  • 4.1 Changing Structure of the German Non-prescription and OTC Self-medication Medicines Market
  • 4.2 Non-Reimbursed Brands Maintaining Sales Growth - Post 2004 Statutory Health Insurance (GMG) Reforms - OTC Self-medication Germany
• 5. The Regulatory Environment for OTC Self-medication Consumer Medicines in Germany
  • 5.1 Self-Medication Definition in Germany
• 6. New Healthcare Reforms impacting on the Non-prescription OTC Self-medication Medicines Sector in Germany
• 7. The Changing Regulatory Environment for the Distribution of Pharmaceutical Products in Germany
• 8. Prices and Margins of Non-prescription Pharmaceutical Products in Germany
• 9. Distribution Channels for OTC (non-prescription) Self-medication Medicines in Germany
  • 9.1. The Changing Structure of the Retail Pharmacy Sector in Germany
  • 9.2 Pharmacy Turnover Analysis Germany
  • 9.3 Economic Impact on Pharmacy Retailing resulting from the 2004 Act to Modernise the Statutory Health Insurance System in Germany
  • 9.4 Development of Retail Pharmacy Chains in Germany
    • Wholesaler Sponsored Virtual Pharmacy Chains in Germany
    • Independent Apotheken Kooperation Groups in Germany
    • Weaknesses of Virtual Pharmacy Chains in Germany
    • Franchise Concept Pharmacy Chains in Germany
    • DocMorris - A Major Breakthrough in Pharmacy Franchise Concepts in Germany
    • Attitudes of German Pharmacists to Membership of Virtual Pharmacy Chains in Germany
• 9.5 Challenges to Ownership Regulations - Retail Pharmacy Chains in Germany
• 9.6 Internet and Mail Order Distribution Channels for OTC Medicines in Germany
• 9.7 Competition from Internet and Mail Order Pharmacies in Germany
• 9.8 Self-medication - The Future for Internet and Mail Order Pharmacy Distribution in Germany
• 9.9 Self-medication - Attitudes of German Pharmacists to Competitive Pricing and Promotion in the Light of New health Reforms
  • On the importance of self-medication to their pharmacy businesses
  • On best useful self-medication industry initiatives
  • On pricing and self-medication business building
  • On mail order and Internet Pharmacies
• 10. Pharmaceutical Wholesalers Germany
  • 10.1 Pharmaceutical Wholesaler Strategies - Key Themes in a Changing Business Environment in Germany
• 11. Pharmaceutical Wholesalers Customer Strategies in Germany
  • 11.1 Pharmaceutical Wholesalers’ Services in Germany
• 12. Free sale or General Sale List (GSL) OTC Self-medication Medicines through Non-Pharmacy Channels in Germany
  • 12.1 Drugstores in Germany
  • 12.2 Independent Drugstores in Germany
  • 12.3 Multiple Drugstore Retailers in Germany
  • 12.4 Health food Shops in Germany
• 13. German Consumer and Self-medication Usage Attitudes and Sources of Information
• 14. Conclusions - Themes of Change Driving the Restructuring of the OTC Selfmedication and non-prescription Market in Germany
  • 14.1 The Impact of Continuing Vertical Integration of Pharmaceutical Wholesalers in Germany on the Suppliers of OTC Self-medication and Non-prescription Pharmaceutical Products

Graphs and Figures

• Graph 1: Development of the German Total Non-prescription Bound and OTC Self-medication Market 2003 - 2006 (estimated)
• Graph 2: Changes in Patient Visits to GPs for Minor Ailments - Pre and Post 2004 Statutory Health Insurance (GMG) Reforms
• Graph 3: Sufferers of Minor Ailments - treatment Preferences Post 2004 Statutory Health Insurance (GMG) Reforms
• Graph 4: - % Share by Main Categories German Self-medication Market 2006
• Graph 5: Growth - Main Categories German OTC Self-medication Market 2003 - 2006
• Graph 6: Share of the German Non-prescription Market - based on the Proportion of Sales attributed to Prescriptions - Pre- 2004 Statutory Health Insurance (GMG) Reforms
• Graph 7: Share of the German Non-prescription Medicines Market by Outlet Type
• Figure 1: Outline Structure of Non-prescription Pharmaceutical Distribution through Pharmacies in Germany
• Graph 8: Growth of Pharmacies in Germany 1993 to 2005
• Graph 9: German Retail Pharmacies - Annual Sales Turnover Analysis
• Figure 2: Wholesaler Customer Services

Tables

• Table 1 Prescription Share of the German Non-prescription bound Medicines Market through Pharmacies 2003 - 2006 Compared to 1999
• Table 2 Changes to Consumers’ Normal Behaviour at the Start of a Minor Ailment - 2004 compared 2005
• Table 3 Leading Competitors’ in the German OTC Market - % € Market Share 2006
• Table 4 Changing Structure of the German Non-prescription market Pre- 2004 Statutory Health Insurance (GMG) Reforms (In pharmacies)
• Table 5 Examples of Manufacturers’ Strategies to Boost Consumer Demand in Germany’s OTC Selfmedication Market - Post 2004 Statutory Health Insurance (GMG) Reforms (2004 - 2006)
• Table 6 Average Wholesaler and Pharmacy Margins in Germany
• Table 7 Chains - Retail Pharmacy Ownership in Germany by Group Size
• Table 8 Chains - Retail Pharmacy Numbers and Ownership in Germany by Region
• Table 9 Structure of Pharmacy Turnover in Germany by Pharmacy Category 2005 compared to 2003
• Table 10 The Principal Virtual Pharmacy Chains (Voluntary Groupings) in Germany 2006
• Table 11 Internet Online Pharmacies in Germany
• Table 12 Concentration of German Pharmaceutical Wholesalers 1981 - 2005
• Table 13 German Pharmaceutical Wholesalers’ % Market Shares in 2006 compared to 1995

Chapter 8 OTC Distribution in Italy

• 1. Introduction - The Italian Non-prescription and OTC Self-medication Market
• 2. Sales Split by Therapeutic Category of Total Non-prescription Bound Market OTC Self-medication in Italy
• 3. Non-prescription and OTC Medicines Category Growth - Italy
• 4. Non-prescription and OTC Medicines Leading Competitors in the Italian Market
• 5. Medicine Classification and the Structure of the Italian OTC Market
• 6. Price Controls - Non-prescription and OTC Self-medication Medicines in Italy
• 7. The Regulatory Environment for Pharmaceutical Distribution Italy
  • 7.1 Self-service Merchandising of OTC Medicines in Italy
  • 7.2 Multiple Ownership of Pharmacies in Italy
  • 7.3 Regulations covering Internet, Distance Selling and Teleshopping of OTC Medicines in Italy
  • 7.4 Regulations Covering Wholesaling of Pharmaceuticals in Italy
  • 7.5 Prices and Margins of Pharmaceuticals in Italy
• 8. Changing nature of Distribution Channels for OTC Self-Medication in Italy
• 9. Growth and Distribution of Retail Pharmacies in Italy
  • 9.1 Community Pharmacy Density by Region in Italy
  • 9.2 Retail Pharmacy Chains in Italy
  • 9.3 Structure of Italian Pharmacy Economics
  • 9.4 Italian Pharmacists’ Attitudes to Self-Medication
• 10. Internet Pharmacies in Italy
• 11. Pharmaceutical Wholesalers Italy
  • 11.1 Phoenix - Comifar Group Italy
  • 11.2 Alleanza Salute Italia (Alliance Boots)
  • 11.3 Farmintesa
• 12. Non-pharmacy Distribution of OTC Medicines in Italy
• 13. The Future for OTC Distribution in Italy

Graphs and Figures

• Graph 1: Development of Total Non-prescription Bound Market 2003 - 2006
• Graph 2: Italy - Non-prescription Medicines % Share by Category 2006
• Graph 3: Non-prescription Bound Medicines Market Growth % by Category 2003 - 2006
• Figure 1: Outline Structure of OTC Pharmaceutical Distribution in Italy

Tables

• Table 1 Leading Competitors’ % € Share in Italy 2006 Total Non-prescription Bound Market
• Table 2 Structure of the Italian Non-prescription Bound and OTC Medicines Market
• Table 3 Growth in Number of Public and Private Pharmacies compared by Region in Italy 2004 - 2006
• Table 4 Pharmacy Density compared to Population Density by Region Italy 2006
• Table 5 Retail Pharmacy Chains in Italy 2006
• Table 6 Pharmacy Share of Hygiene and Toiletry Categories - Italy
• Table 7 Leading Pharmaceutical Wholesalers in Italy

Chapter 9 OTC Distribution in the Netherlands

• 1. Introduction - The Dutch Non-prescription and OTC Self-care Market
• 2. Key Therapeutic Categories in the Dutch OTC Self-medication Market
• 3. Dutch Consumer Healthcare Non-prescription and OTC Self-medication Growth Rates by Therapeutic Category 2003 - 2006
• 4. Self-medication - Leading Competitors in the Netherlands
• 5. Classification of Medicines in the Netherlands - Proposed New Three-class System to include General Sale and Pharmacy only
• 6. The Prescription Sector in the Netherlands
• 7. Regulations to Abolish Price Fixing of OTC Medicines in the Netherlands
• 8. Structure of Distribution for OTC Self-Medication in the Netherlands
• 10. Self-selection and Point of Purchase Merchandising of OTC Self-medication Medicines in Dutch Drugstores
• 11. Self-medication - Private Label OTC (non-prescription) Medicines Sales through Drugstores in the Netherlands
• 12. OTC (non-prescription) Medicines Sales through Grocery Outlets in the Netherlands
• 13. Pharmacies - The Netherlands
• 14. Self-medication - Internet Pharmacies in the Netherlands
• 15. DocMorris international On-line Pharmacy Provider
• 16. OTC (non-prescription) Medicines Channel Influences on Consumer Sources of Purchase and Choice of Brand for Self-medication in the Netherlands
• 17. OTC Retail Prices - the Netherlands
• 18. Pharmaceutical Wholesalers in The Netherlands
• 19. Wholesaler Private Label OTC (non-prescription) Medicine Brands in the Netherlands
• 20. Conclusions The Future for OTC Self-medication Distribution in the Netherlands. Graphs and Figures

• Graph 1: Sales Development of the Dutch Non-prescription OTC Self-medication Market 2003 - 2006 (est) (euros millions consumer purchase prices)
• Graph 2: Dutch OTC Self-medication Market Share of Sales by Category 2006
• Graph 3: Netherlands OTC Self-medication Categories - % Sales Growth
• Graph 4: Share of OTC Self-medication Turnover by Therapeutic Category and Channel 2006
• Graph 5: Growth of Pharmacies and Drugstores (Druggists) in the Netherlands 1996 - 2005

Tables

• Table 1 Leading Competitors’ € Market Share 2005 Non-prescription Bound Sector Compared to the OTC Sector
• Table 2 Average Turnover of OTC Medicines by Retail Channel in the Netherlands 2006
• Table 3 Pharmacy Chains in the Netherlands 2003 - 2006
• Table 4 Market Shares of Pharmaceutical Wholesalers the Netherlands 2006

Chapter 10 OTC Distribution in Spain

• 1. Introduction - The Spanish OTC Medicines Market
• 2. Share of the Total Non-prescription Bound and OTC Self-medication Medicines Market by Therapeutic Category in Spain
• 3. OTC Self-medication Medicines Therapeutic Category Growth - Spain
• 4. Leading Non-prescription Pharmaceutical Company Competitors in the Spanish Market
• 5. Structure of the Spanish Non-prescription and OTC Medicines Market
• 6. The Regulatory Environment for Non-prescription and OTC Medicines in Spain
  • 6.1 Classification of Medicines in Spain
  • 6.2 Registration of Non-prescription and OTC Medicines in Spain
• 7. Issues affecting the Prescription Sector for Products classified as Non-prescription Medicines in Spain
  • 7.1 Reimbursement of Medicinal Products not requiring a Prescription in Spain
  • 7.2 Pricing and Price Controls of Non-prescription and OTC Medicines in Spain
• 8. Advertising of OTC Medicines in Spain
  • 8.1 Regulation of Trade Names for Non-prescription and OTC Medicines in Spain
• 9. The Regulatory Environment for Pharmaceutical Distribution in Spain
• 10. Structure of Distribution for OTC Self-Medication in Spain
• 11. Growth of Pharmacies in Spain
• 12. Regulatory Controls on the Number of Pharmacies in Spain
• 13. Pharmacy Density by Region in Spain
• 14. Spanish Pharmacy Economics
  • 14.1 Pricing and Margins
• 15. Spanish Consumer Attitudes to Self-Medication
• 16. Pharmaceutical Wholesalers in Spain
  • 17.1 Leading Pharmaceutical Wholesalers in Spain - Market Shares and Strategies
  • 17.2 Cofares
  • 17.3 SA Farmacéutica Aragonesia (SAFA)
• 18. The Future of OTC Distribution in Spain

Graphs and Figures

• Graph 1: Development of Total Non-prescription Bound Market in Spain 2003 - 2006
• Graph 2: - % Share by Main Categories Spanish Self-medication Market 2006
• Graph 3: Growth - Main Categories Spanish OTC Self-medication Market 2003 - 2006

Tables

• Table 1 Leading Competitors’ € Market Share 2006 Non-prescription Bound Sector Compared to the OTC Sector
• Table 2 Growth of Pharmacies in Spain 1986 to 2005
• Table 3 Number of Pharmacies by Province - Spain
• Table 4 % of Pharmacies by Region Compared to % of Population - Spain
• Table 5 Share of Pharmacy Sales by Categories by Value - Spain
• Table 6 Spain - Consumers Using OTC Medicines for Minor Ailments
• Table 7 Spain - Pharmaceutical Wholesaler Coverage - Number of Depots by Region and Number of Pharmacies Served
• Table 8 Spain - Pharmaceutical Wholesalers’ Market Shares 2006
• Table 9 Cofares Group of Regional Companies - Spain

Chapter 11 OTC Distribution in the UK

• 1. Introduction - The UK OTC Medicines Market
• 2. Sales Split of Total Non-prescription and OTC Self-medication Medicines Market by Therapeutic Category in the UK
• 3. Leading Competitors in the Non-prescription Medicines Market UK
• 4. Structure of the Market Demand Non-prescription and OTC Medicines in the UK
• 5. The Regulatory Environment for Non-prescription and OTC Medicines in the UK
• 5.1 Classifications of Medicines in the UK
• 5.2 Legal Definition of Self-Medication in the UK
• 6. Structure of Distribution Channel Systems for Non-prescription Pharmaceuticals in the UK
• 7. Consumer Source of Purchase and Share of UK OTC Medicines Market by Outlet Type
• 8. The Retail Pharmacy Sector in the UK
  • 8.1 New Role for Pharmacies in the UK - New Pharmacy Contract
  • 8.2 Pharmacy Density in the UK
• 9. Ownership of Pharmacies in the UK
  • 9.1 Independent Pharmacies in the UK
  • 9.2 ‘Virtual’ Chains of Pharmacies (Symbol Groups) in the UK
  • 9.3 Leading Pharmacy Chains in the UK
    • Alliance UniChem and Boots the Chemist Merger in the UK
    • Celesio-Lloydspharmacy
    • Co-operative Group Pharmacy
    • L. Rowland (Phoenix)
• 10. Importance of Supermarket Chains and Discount Drugstores for OTC Selfmedication Distribution in the UK
• 11. Internet as a Consumer Channel for Pharmaceuticals in the UK
• 12. Pharmaceutical Wholesaling in the UK
  • 12.1 Pharmaceutical Wholesaler Strategies in the UK - AAH Pharmaceuticals (Celesio), UniChem (Alliance UniChem) and Phoenix
    • AAH Pharmaceuticals (Celesio
    • UniChem (Alliance Boots)
    • Phoenix
  • 12.2 Conclusion Wholesaler Strategies in the UK
• 13. The Future for the Distribution of OTC Medicines in the UK
• 14. OTC Manufacturers’ Strategies in the UK
  • 14.1 Category Management for OTC Medicine Manufacturers in the UK
  • 14.2 Category Management Criteria for OTC Medicines Manufacturers in the UK

Graphs and Figures

• Graph 1: UK - Development of the Total Non-prescription and OTC Self-medication Medicines Market 2003 - 2006 (est)
• Graph 2: UK - % Share OTC Self-medication Medicines Market 2006 (est) by Therapeutic Category
• Graph 3: UK - % Growth of OTC Self-medication Medicines Market 2003 -2006 (est) by Therapeutic Category
• Graph 4: Pharmacy Groupings in the UK by Number of Stores
• Graph 5: Leading Supermarket Groups % Share of UK Grocery Market in the UK

Tables

• Table 1 Leading Competitors’ € Market Share Non-prescription Bound Sector Compared to the OTC Sector
• Table 2 Consumer Sources of Purchase for OTC Self-Medication by Channel in the UK 2006
• Table 3 Share of Pharmacies in the UK by Region
• Table 4 Virtual Pharmacy Chains and in the UK
• Table 5 Leading Pharmacy Chains and Number of Outlets in the UK
• Table 6 Post Merger Boots Sales in the UK compared to Pre-merger Boots the Chemist Sales - % by Category 2006
• Table 7 Number of Pharmacies Located in Supermarket Chains in the UK
• Table 8 Leading Pharmaceutical Wholesalers in the UK - 2005/2006
• Table 9 Celesio Wholesale Turnover € Millions 2005/6
• Table 10 UniChem Turnover in the UK 2005/6 (excluding Boots Wholesale Turnover)

Chapter 12 OTC Distribution in Austria & Switzerland

• Austria
• 1. Introduction - The Austrian OTC Medicines Market
• 2. Leading OTC (non-prescription) Medicines Companies in Austria
• 3. The Regulatory Environment for OTC (non-prescription) Medicines in Austria
  • 3.1 Classification of Medicines in Austria
  • 3.2 Registration of OTC Medicines in Austria
  • 3.3 Regulations covering the Distribution of OTC Medicines in Austria
  • 3.4 Regulations covering the Control of Pharmacies in Austria
  • 3.5 Regulations covering Pricing of OTC (non-prescription) Medicines in Austria
  • 3.6 Regulations covering the Advertising of OTC (non-prescription) Medicines in Austria 7
• 4. The Distribution Environment for OTC (non-prescription) Medicines in Austria
  • 4.1 The Retail Pharmacy Environment for OTC (non-prescription) Medicines in Austria
  • 4.2 Retail Pharmacy Economics in Austria
• 5. Prices and Margins for OTC (non-prescription) Medicines in Austria
• 6. Pharmaceutical Wholesalers in Austria
  • 6.1 Ownership of Pharmaceutical Wholesalers in Austria
• 7. The Future for OTC Distribution in Austria
  • Switzerland
• 8. Introduction - The Swiss OTC (non-prescription) Medicines Market
• 10. The Regulatory Environment for OTC Medicines in Switzerland
  • 10.1 Classification of Medicines in Switzerland
  • 10.2 Pharmaceutical Product Classifications in Switzerland
  • 10.3 Registration of OTC Medicines in Switzerland
  • 10.4 Regulations covering the Distribution of OTC (non-prescription) Medicines in Switzerland
  • 10.5 Regulations covering Pharmacy or Drugstore Ownership in Switzerland
  • 10.6 Pricing of OTC Medicines in Switzerland
  • 10.7 Regulations covering the Advertising of OTC (non-prescription) Medicines in Switzerland
  • 10.8 Regulations covering the Use of Trademarks of OTC (non-prescription) Medicines in Switzerland
• 11. Healthcare Reforms in Switzerland and their Impact on the Swiss OTC Pharmaceuticals Industry
• 12. The Distribution Environment in Switzerland
  • 12.1 OTC (non-prescription) Medicines in Retail Pharmacies in Switzerland
  • 12.2 Sources of Pharmacy Turnover Switzerland
  • 12.3 Self-medication on the Net - Swiss Pharmacies engaged in e-commerce
  • 12.4 Distribution of OTC (non-prescription) Medicines through Drugstores in Switzerland
• 13. Prices and Margins of OTC Medicines in Switzerland
• 14. Swiss Pharmaceutical Wholesalers
• 15. The Future for OTC Distribution in Switzerland

Graphs and Figures

• Graph 1: Austria - Development of the Total Non-prescription and OTC Self-medication Market 2003 - 2006
• Graph 2: Austria -Total Non-prescription and OTC Self-Medication Market - Split by Major Therapeutic Category (Value) 2006
• Graph 3: Switzerland - Development of the Total Non-prescription Market 2003 -2006
• Graph 4: Switzerland -% Key Category Share OTC Self-medication Market 2006
• Graph 5: Switzerland - Growth History Key Non-prescription OTC Self-medication Categories 2003 - 2006
• Graph 6: Switzerland - Split of Non-prescription and OTC Medicines Sales through Pharmacies, Drugstores & Dispensing Doctors 2005

Tables

• Table 1 Top 5 Companies % Share of the Total Non-prescription OTC Self-medication Medicines Market Austria 2006
• Table 2 Leading Drugstore Chains in Switzerland - 2006
• Table 3 Leading Swiss Pharmacy Wholesalers

Chapter 13 OTC Distribution in the Nordic Region

• Sweden, Denmark, Finland and Norway
• Sweden
• 1. Introduction - The Swedish Non-prescription and OTC Self-medication Medicines Market
• 2. Manufacturers of OTC Medicines in Sweden
• 3. The Regulatory Environment for OTC Medicines in Sweden
  • 3.1 Classification of Medicines in Sweden
  • 3.2 Registration of OTC Medicines in Sweden
  • 3.3 Regulations covering the Distribution of OTC Medicines in Sweden
  • 3.4 Pricing of OTC Medicines in Sweden
  • 3.5 Advertising Regulations for OTC Medicines in Sweden
  • 3.6 Use of Trademarks for OTC Self-medication Medicines in Sweden
• 4. Distribution Environment for OTC Self-medication Medicines in Sweden
  • 4.1 Pharmacy Distribution for OTC Self-medication Medicines in Sweden
  • 4.2 The Retail Environment for OTC Self-medication Medicines in Sweden
• 5. Changing Structure of Pharmaceutical Wholesalers in Sweden
  • 5.1 Prices and Margins
• 6. Internet and Distance Selling of OTC Self-medication Medicines in Sweden
• Denmark
• 7. Introduction - The Danish OTC Medicines Market
• 8. Sales Split of Key Categories of OTC Medicines in Denmark
• 9. The Regulatory Environment for OTC Self Medication Medicines in Denmark
  • 9.1 Classification of Medicines in Denmark
  • 9.2 Registration of OTC Self-medication Medicines in Denmark
• 10. Regulations for the Distribution of OTC Self-medication Consumer Medicines in Denmark
• 11. Regulations for the Distribution of Pharmacy Only OTC Self-medication Consumer Medicines in Denmark
  • 11.1 Regulations covering Internet and Distance Selling of OTC Medicines in Denmark
• 12. Pricing Regulations for OTC Medicines in Denmark
• 13. Advertising Regulations for OTC Self-medication Consumer Medicines in Denmark
  • 13.1 Rules Applying to TV Advertising of OTC Medicines in Denmark
  • 13.2 Rules Applying to Radio Advertising of OTC Medicines in Denmark
  • 13.3 Rules Applying to Print Advertising of OTC Medicines in Denmark
• 14. Trade Margins / VAT for Pharmaceuticals in Denmark
• 15. Rules Covering Use of Trademarks for Pharmaceuticals in Denmark
• 16. The Distribution Environment for OTC Self-medication Consumer Medicines in Denmark
  • 16.1 OTC Self-medication Consumer Medicine Sales through Pharmacies in Denmark
  • 16.2 OTC Sales through Non-Pharmacy Outlets in Denmark
  • 16.3 OTC Self-medication Consumer Medicines - Distance Selling through Internet Pharmacies in Denmark
• 17. Restructuring of Pharmaceutical Wholesalers’ Network in Denmark
• Finland
• 18. Introduction - The Finnish OTC Self-medication Consumer Medicines Market
• 19. Sales Split of Key Categories of OTC Self-medication Consumer Medicines in Finland 20
• 20. The Regulatory Environment for OTC Medicines in Finland
  • 20.1 Registration and Classification of Medicines in Finland
  • 20.2 Registration of OTC Medicines in Finland
  • 20.3 Patient Information Requirements in Finland for OTC Medicines
• 21. Regulations for the Distribution of OTC Medicines in Finland
• 22. Pricing Regulations for OTC Medicines in Finland
• 23. Advertising Regulations for OTC Self-medication Medicines in Finland
• 24. Trade Margins / VAT for OTC Medicines in Finland
• 25. Use of Trademarks for OTC Self-medication Consumer Medicines in Finland
• 26. Customer Information Channels for OTC Self-medication Consumer Medicines in Finland
• 27. The Distribution Environment for OTC Self-medication Consumer Medicines in Finland
  • 27.1 Pharmacies in Finland
  • 27.2 Self-medication - Distance Selling through Internet Pharmacies in Finland
  • 27.3 Sources of Pharmacy Sales Turnover in Finland
• 28. Restructuring of the Pharmaceutical Wholesaler Network in Finland
• Norway
• 29. Introduction - The Norwegian OTC Self-medication Consumer Market
  • 29.1 Sales Split of the Main OTC Self-medication Consumer Medicine Categories in Norway
• 30. Leading Competitors in the Norwegian OTC Self-medication Consumer Market
• 31. The Regulatory Environment for OTC Medicines in Norway
  • 31.1 Classification of Medicines in Norway
  • 31.2 Registration of OTC Medicines in Norway
  • 31.3 Regulations for the Distribution of OTC Medicines in Norway
  • 31.4 Pricing Regulations for OTC Medicines in Norway
  • 31.5 Advertising Regulations for OTC Medicines in Norway
• 32. Trade Margins and VAT for OTC Medicines in Norway
• 33. Rules Covering Use of Trademarks for Pharmaceuticals in Norway
• 34. The Distribution Environment for OTC Self-medication Consumer Medicines in Norway
  • 34.1 The Structure of Distribution Channels for OTC Self-medication Consumer Medicines in Norway
  • 34.2 Retail Pharmacies in Norway
  • 34.3 Self-medication - Distance Selling through Internet Pharmacies in Norway
  • 34.4 Non-pharmacy and Grocery Distribution of OTC Medicines in Norway
• 35. Pharmaceutical Wholesalers in Norway
• 36. Distribution of OTC Self-medication Consumer Medicines in the Nordic Region Summary Conclusions

Graphs and Figures

• Graph 1: Sweden - Development of the Non-prescription and OTC Self-medication Medicines Market 2003 - 2006 (est
• Graph 2: Denmark - Development of the Total Self-Medication Market at Consumer Prices euromillions 2003 - 2006
• Graph 3: Denmark - Danish Sales of GSL Medicines in Non-pharmacy Outlets 2003 - 2006 (est.) Retail Selling Prices in euro Millions
• Graph 4: Finland - Development of the Total Non-prescription, OTC Self-medication Consumer Market 2003 - 2006 (Consumer Prices euros millions)
• Graph 5: Norway - Development of the Total Non-prescription Pharmaceutical Market 1999 - 2004 - (Consumer Prices euro millions)
• Graph 6: Nordic Region - % Share of the Total Non-prescription Pharmaceutical Market (Consumer Prices euro millions)

Tables

• Table 1 Sweden - Total Self Medication Sales - Split by Major Category (Value)
• Table 2 Denmark Total OTC Self Medication Sales - Split by Major Category (Value) 2006
• Table 3 Types of Outlet Distributing OTC Self-medication in Denmark
• Table 4 Finland Total OTC Self-medication Consumer Pharmaceutical Sales - Split by Major Category (Value) 2006
• Table 5 Norway Total OTC Self-Medication Sales - Split by Major Category (Value) 2006
• Table 6 Top OTC Pharmaceutical Companies in Norway % Market Share 2006
• Table 7 OTC Medicines Prices in Pharmacies - LMI Survey
• Table 8 Retail Outlets Selling OTC Medicines in Norway
• Table 9 Market Shares Leading Retail Pharmacy Chains in Norway 2006

Chapter 14 OTC Distribution in Central & Eastern Europe

• Poland, Hungary, Czech Republic, Slovakia and Slovenia
• Introduction Market Opportunities for OTC Self-medication Medicines in Central and Eastern Europe
• Poland
• 1. Introduction - The Polish OTC Self-medication Market
• 2. Poland - Sales Split of Non-prescription OTC Self-medication by Key Therapeutic Categories in Poland
• 3. Non-prescription OTC Medicines Therapeutic Category Growth in Poland 2003 - 2006
• 4. Regional Split of the Polish Pharmaceutical Market
• 5. Leading Competitors in the Polish OTC Medicines Market
• 6. The Regulatory Environment for Non-prescription and OTC Self-medication Medicines in Poland
  • 6.1 Classification of Medicines in Poland
  • 6.2 Registration of OTC Medicines in Poland
• 7. Regulations Governing Marketing and Distribution Channels for OTC Medicines in Poland
  • 7.1 Pharmacy and Non-pharmacy Retail Channels for OTC Medicines in Poland
  • 7.2 Controls on Pricing and Margins of OTC Medicines in Poland
  • 7.3 Advertising and Promotion of OTC Medicines in Poland
• 8. Changing Distribution Environment for Non-prescription OTC Self-medication Medicines in Poland
  • 8.1 The Retail Pharmacy Environment for OTC Self-medication in Poland
• 9. Main Pharmaceutical Wholesalers in Poland
  • Polska Grupa Farmaceutyczna (PGF)
  • Farmacol
  • Prosper
  • Torfarm
  • Orfe Group
  • CF Cefarm
  • Phoenix
• 9.1 Role of Pharmaceutical Wholesalers in Poland
• Hungary
• 10. Introduction - The Hungarian Self-Medication Market
  • 10.1 Market for Registered Non-prescription OTC Medicines in Hungary
  • 10.2. Hungary - Sales Split of Key Therapeutic Categories of OTC Self-medication Medicines
• 9.3 Main Competitors Non-prescription Medicines in Hungary
• 11. The Regulatory Environment for OTC Self-medication Medicines in Hungary
  • 11.1 Directives
  • 11.2 Medicines Classification in Hungary
  • 11.3 Registration of OTC Medicines in Hungary
  • 11.4 Regulations for Distribution of OTC Medicines in Hungary
  • 11.5 Pricing of OTC Medicines in Hungary
  • 11.6 Regulations on Advertising OTC Medicines in Hungary
  • 11.7 Trade Margins / VAT on OTC Medicines in Hungary
  • 11.8 Use of Trademarks for OTC Medicines in Hungary
• 12. The Distribution Environment for Self-Medication Hungary
  • 12.1 Pharmaceutical Wholesalers in Hungary
  • 12.2 Growth of Retail Pharmacies in Hungary
  • 12.3 Hungary - Classification of Pharmacies by Size, Location and Market Share
• 13. General Sales List for OTC Self-medication Medicines in Hungary
• Czech Republic
• 14. Introduction - The Czech Republic OTC Market
• 15. Sales Split of Key Categories of OTC Medicines in the Czech Republic
• 16. The Regulatory Environment for OTC Self-medication Medicines in the Czech Republic
  • 16.1 Medicine Classifications in the Czech Republic
  • 16.2 Registration of OTC Medicines in the Czech Republic
• 17. Regulations Governing Marketing and Distribution Channels for OTC Medicines in the Czech Republic
  • 17.1 Permitted Retail Channels for OTC (non-prescription) Self-medication Medicines in the Czech Republic
  • 17.2 Pharmacy Ownership and Self-service Regulations for OTC Medicines in the Czech Republic
  • 17.3 Pricing of OTC Medicines in the Czech Republic
  • 17.4 Pricing for Reimbursed medicines in the Czech Republic
  • 17.5 Regulations on Advertising OTC Medicines in the Czech Republic
  • 17.6 Controls on Advertising of OTC Medicines in the Czech Republic
  • 17.7 Patient Information Requirements for OTC Medicines in the Czech Republic
  • 17.8 Use of Trademarks for OTC Medicines in the Czech Republic
• 18. Trade Margins / VAT for OTC Self-medication Medicines in the Czech Republic
• 19. The Distribution Environment for OTC (non-prescription medicines in the Czech Republic
  • 19.1 Pharmaceutical Wholesalers in the Czech Republic
• 20. Growth of Pharmacies in the Czech Republic
  • 20.1 Leading Pharmacy Chains in the Czech Republic
  • 20.2 Non-pharmacy Distribution in Czech Republic
  • 20.3 Internet Pharmacies and Distance Selling of Pharmaceuticals in the Czech Republic
• Slovak Republic
• 21. Introduction - The Slovak Republic OTC Medicines Market
• 22. Sales Split of Key Therapeutic Categories of OTC Self-medication Medicines in the Slovak Republic
• 23. The Regulatory Environment for OTC Medicines in the Slovak Republic
  • 23.1 Medicinal Classifications in the Slovak Republic
  • 23.2 Registration of OTC Medicines in the Slovak Republic
  • 23.3 Regulations on the Distribution of OTC Medicines in the Slovak Republic
  • 23.4 Pricing Regulations for OTC Medicines in the Slovak Republic
  • 23.5 Reference Pricing System - Reimbursed Medicines in the Slovak Republic
  • 23.6 Rules on Advertising OTC Medicines in the Slovak Republic
  • 23.7 Advertising Controls on OTC Medicines in the Slovak Republic
  • 23.8 Patient Information Requirements for OTC Medicines in Slovakia
• 24. Trade Margins / VAT for OTC Medicines in Slovakia
• 25. Use of Trade Marks for OTC Medicines in Slovakia
• 26. The Distribution Environment for Non-prescription and OTC Self-medication Medicines - Slovak Republic
  • 26.1 Pharmaceutical Wholesalers in Slovakia
  • 26.2 Pharmacies and Pharmacy Chains in Slovakia
• Slovenia
• 27. Introduction - The Slovenian OTC Self-medication Market
• 28. Slovenia - Sales Split of OTC Self-medication by Key Therapeutic Categories
• 29. The Regulatory Environment for OTC Medicines in Slovenia
  • 29.1 Directives
  • 29.2 Medicinal Classifications for OTC Medicines in Slovenia
  • 29.3 Registration of OTC Medicines in Slovenia
  • 29.4 Regulations on the Distribution of OTC Medicines in Slovenia
  • 29.5 Pricing Controls on OTC Medicines in Slovenia
  • 29.6 Rules on Advertising OTC Medicines in Slovenia
  • 29.7 Patient Information Requirements for OTC Medicines in Slovenia
• 30. Trade Margins / VAT for OTC Medicines in Slovenia
• 31. Use of Trade Marks for OTC Medicines in Slovenia
• 32. The Distribution Environment for Non-prescription OTC Self-medication Medicines in Slovenia
  • 32.1 Pharmacies in Slovenia
  • 32.2 Internet Pharmacies and Distance Selling of Pharmaceutical Products in Slovenia

Graphs and Figures

• Graph 1: Poland - Development of the Total Non-prescription OTC Self-medication Medicine Market 2003 - 2006
• Graph 2: Poland - Total Self-Medication Sales - Split by Major Therapeutic Category (Value) 2006
• Graph 3: Poland - Non-prescription OTC Self-medication Therapeutic Category % € Growth Rates 2003 - 2006
• Graph 4: Hungary - Development of Total Non-prescription and OTC Self-medication Market (Retail Sales Prices - euros millions) 2003 - 2006
• Graph 5: Hungary Non-prescription OTC Self-medication Sales in Pharmacies - % Split by Major Therapeutic Category (Value) 2006 Hungary
• Graph 6: Hungary - Non-prescription and OTC Self-medication Medicines - Sales Growth by Therapeutic Category 2003 - 2006
• Graph 7: Main Competitors Non-prescription Medicines in Hungary
• Graph 8: Czech Republic - Development of the Total Non-Prescription and OTC Self-medication Market 2003 - 2006 (euos millions at Consumer Prices)
• Graph 9: Czech - OTC Self Medication Sales - Split by Major Therapeutic Category (Value) 2006
• Graph 10: Czech Republic - Non-prescription and OTC Self-medication Medicines - Sales Growth by Therapeutic Category 2003 - 2006
• Graph 11: Slovak Republic - Development of the Non-Prescription OTC Self-medication Medicines Market 2003 - 2006
• Graph 12: Slovak Republic - Non-prescription and OTC Self-medication Medicines - Sales Growth by Therapeutic Category 2003 - 2006
• Graph 13: Slovenia - Development of the Total Non-Prescription Market 2003 - 2006 (Consumer prices)

Tables

• Table 1 Regional Split of the Polish Pharmaceutical Market
• Table 2 Average Wholesaler and Pharmacy Margins in Hungary 2006
• Table 3 Market Shares of the Main Pharmaceutical Wholesalers in Hungary - 2006
• Table 4 Hungary Classification of Pharmacies by Size, Location and Market Share
• Table 5 Pharmaceutical Trade Mark-ups in the Czech Republic
• Table 6 € % Share Pharmaceutical Full Line Wholesalers in the Czech Republic
• Table 7 Czech RepublicGrowth in Numbers of Pharmacies 1990 - 2005
• Table 8 Slovak Republic - Pharmaceutical Trade Margins and VAT
• Table 9 Slovenia - Pharmaceutical Trade Margins and VAT

Chapter 15 Conclusions of the Report Exploring New Frontiers - OTC Distribution in Europe

• 1. Growth trends and outline Prognosis for Europe’s Non-prescription OTC Selfmedication and Self-care Markets to 2012
  • 1.1 Growth Clusters by Country - European Non-prescription and OTC Selfmedication Market
• 2. Summary of the Main Factors Driving Change in Europe’s Non-prescription, Selfmedication and Self-care Markets to 2012
  • 2.1 The Legacy of Change Resulting from Health Reforms in Germany
  • 2.2 Overturning of Pharmacy Establishment Laws in many European Markets (France, Italy, Spain and Austria)
  • 2.3 Abolition of the Retail Pharmacy State Monopoly in Sweden
  • 2.4 The Concentration of Pharmaceutical Wholesaler Buying Power across European Borders
  • 2.5 The rapid growth of large ‘virtual’ pharmacy chains especially in Germany, Switzerland and the Netherlands
  • 2.6 Growth of General Sale Listing (GSL) of selective OTC medicines for Selfmedication across Europe - Influence of Major Mass Market Chains
  • 2.7 Mass Market Retail Chains acquisition of Pharmacies Para-pharmacies and OTC Licenses in Europe
  • 2.8 Competing in the Mass-Market Implications for Brand Market Shares of OTC Self-medication Medicines in Europe
  • 2.9 Unfolding development of Internet pharmacy in the European Union
• 3. Developments in Poland, Hungary, Czech Republic, Slovakia, Slovenia
• 4. The Changing Consumer Healthcare Market - Estimating the Speed of Change by Exploring Regulatory Freedoms in Europe’s Main Markets for OTC Self-medication Medicines
  • 4.1 Main European States Ranked by Marketing Freedoms for OTC Medicines
  • 4.2 Main European States Ranked by Pharmacy Regulatory Freedoms
  • 4.3 Main European States OTC Medicines Markets Ranked by Total Regulatory Freedoms
• 5. The Key Challenges to Non-prescription and OTC
  • Self-medication Medicines Manufacturers in Europe to 2012
  • 5.1 Balancing Competitive Intensity between Brands and Competitive Intensity between Retail Groups - a major New Challenge for Consumer Healthcare Companies many European Markets
  • 5.2 Consumer Healthcare Suppliers Decisions in Response to Distribution Channel Changes in Europe
• 6. Conclusions - Exploring New Frontiers in the European Consumer Healthcare Market Lessons learned over the 15 years and six editions of this Study

Graphs and Figures

• Graph 1: Forecast of Sales of the Total Non-prescription Bound and OTC Self-medication market for 18 major Markets - € millions at Consumer Purchase Prices 2007 - 2012
• Figure 1: Europe - 18 Country Study -Non-prescription and OTC Self- medication Markets - Growth Cycle Analysis based on Market Share of Growth Clusters
• Figure 2: Increasing Competitive Intensity in a Changing Multi channel Supply Chain - Impacts on Consumer Healthcare Brands in Europe
• Figure 3: Framework - Supplier Decision Steps in Response to Changes in the Supply Chain

Tables

• Table 1 Europe -18 Country Study Prognosis and Key Issues for the Strategic Agenda by Country to 2012
• Table 2 Europe’s Main OTC Medicines Markets Ranked by Marketing Freedoms 2007 compared to 2005
• Table 3 Europe’s Main OTC Medicines Markets Ranked by Pharmacy Freedoms 2007 compared to 2005
• Table 4 Europe’s Main OTC Markets Ranked by Total Freedoms 2005 compared to 2007